PNC Financial Services Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Buy
58,856
+465
+0.8% +$8.05K ﹤0.01% 1179
2025
Q1
$1.28M Buy
58,391
+238
+0.4% +$5.21K ﹤0.01% 1072
2024
Q4
$1.86M Sell
58,153
-309
-0.5% -$9.86K ﹤0.01% 934
2024
Q3
$1.69M Sell
58,462
-626
-1% -$18.1K ﹤0.01% 974
2024
Q2
$2.27M Buy
59,088
+478
+0.8% +$18.3K ﹤0.01% 862
2024
Q1
$3.45M Sell
58,610
-61,175
-51% -$3.6M ﹤0.01% 742
2023
Q4
$7.17M Buy
119,785
+45
+0% +$2.69K 0.01% 564
2023
Q3
$4.55M Sell
119,740
-2,611
-2% -$99.3K ﹤0.01% 652
2023
Q2
$11.1M Buy
122,351
+60,886
+99% +$5.55M 0.01% 468
2023
Q1
$4.05M Buy
61,465
+510
+0.8% +$33.6K ﹤0.01% 689
2022
Q4
$3.15M Buy
60,955
+3,009
+5% +$156K ﹤0.01% 748
2022
Q3
$3.96M Buy
57,946
+194
+0.3% +$13.3K ﹤0.01% 673
2022
Q2
$2.61M Buy
57,752
+53
+0.1% +$2.4K ﹤0.01% 799
2022
Q1
$2.93M Buy
57,699
+44,751
+346% +$2.27M ﹤0.01% 821
2021
Q4
$612K Buy
12,948
+6,890
+114% +$326K ﹤0.01% 1564
2021
Q3
$200K Buy
6,058
+110
+2% +$3.63K ﹤0.01% 2210
2021
Q2
$376K Hold
5,948
﹤0.01% 1795
2021
Q1
$255K Hold
5,948
﹤0.01% 2026
2020
Q4
$340K Hold
5,948
﹤0.01% 1744
2020
Q3
$179K Buy
5,948
+940
+19% +$28.3K ﹤0.01% 1999
2020
Q2
$164K Buy
5,008
+8
+0.2% +$262 ﹤0.01% 2040
2020
Q1
$134K Hold
5,000
﹤0.01% 2043
2019
Q4
$154K Sell
5,000
-3,760
-43% -$116K ﹤0.01% 2232
2019
Q3
$210K Sell
8,760
-1,100
-11% -$26.4K ﹤0.01% 2103
2019
Q2
$251K Sell
9,860
-4,280
-30% -$109K ﹤0.01% 2035
2019
Q1
$276K Buy
14,140
+4,760
+51% +$92.9K ﹤0.01% 1952
2018
Q4
$124K Buy
9,380
+2,440
+35% +$32.3K ﹤0.01% 2345
2018
Q3
$124K Sell
6,940
-440
-6% -$7.86K ﹤0.01% 2465
2018
Q2
$162K Buy
+7,380
New +$162K ﹤0.01% 2313